Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2025
[211 Page Report] The global electrophysiology market is projected to reach USD 10.6 billion by 2025 from USD 6.8 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025. Technological advancements; new entrants in the market; growing investments, funds, and grants; and increasing incidence of target diseases and procedures are responsible for the significant growth of the market during the review period.
COVID-19 Impact on the global electrophysiology market
The impact of the coronavirus pandemic and the lockdown it triggered is visible in various industries, including the electrophysiology market. Enforcement of new guidelines and regulations are hampering the growth of this industry. Moreover, limited access to clinics, social distancing, the lockdown of the population, which results in slow-down in patient flow and referrals, has also impacted the market growth.
Electrophysiology Market Dynamics
Driver: Increasing incidence of target diseases and procedures
AF is the most common arrhythmia diagnosed in clinical practices, affecting over 886,000 new people each year in Europe. By 2030, the number of people with AF is expected to increase by up to 70% of the population; by 2050, Europe is expected to have the highest number of patients with AF (Source: 2018 Report on Burden of Atrial Fibrillation). In the US, AF affected between about 2.7 million to 6.1 million people in 2012; this is estimated to rise to 12.1 million by 2030 (Source: CDC). According to a study published in the Medical Journal of Australia in August 2015, the number of AF patients aged above 55 years in Australia was 328,562 in June 2014 and is estimated to reach to over 600,000 cases by 2034. The rising incidence of these diseases will correspondingly drive the demand for EP procedures, which makes it a primary growth driver for the electrophysiology market. For instance, global ablation procedure numbers are predicted to grow from 973,220 in 2017 to 1,455,000 per year by 2022; within this category, complex ablations (AF and VT) is expected to increase by 13.5% annually from 440,629 in 2017 to 830,390 in 2022 (Source: BioSig Technologies, Annual Report, 2019).
Restraint: High cost of electrophysiology products and inadequate reimbursement
Currently, the electrophysiology market is extremely competitive in terms of pricing owing to the competitive intensity among existing players. Most of these products are premium-priced products, including the cardiac 3D mapping systems and EP recording systems. The average list price of cardiac 3D mapping systems ranges from USD 250,000 to 800,000 (Source: APN Health). The cost of an EP recording system is USD 160,000 (Source: BioSig Technologies, Annual Report, 2019). Owing to the high capital, training, and maintenance costs, EP procedures are generally expensive. For instance, the average cost of a catheter ablation procedure ranges from USD 4,000–6,500. This, coupled with the unfavorable reimbursement scenario for these products in several countries, makes them unaffordable for a large section of the target patient population.
Opportunity: Emerging markets
Emerging markets are expected to offer significant growth opportunities for players in the cardiac mapping systems market, mainly due to their increasing patient population, rising adoption of cardiac mapping systems, growing awareness of CVDs, rising disposable incomes, improving healthcare infrastructure, and comparatively lenient guidelines as compared to developed countries. The emerging countries have registered a sustained increase in the number of surgical procedures during the past decade, driven by the growing target patient population and the rising number of CVD-related deaths, along with rising medical tourism.
Regulatory policies in Asia Pacific are more adaptive and business-friendly. Increasing competition in mature markets will further compel electrophysiology device manufacturers to focus on emerging markets in the coming years.
Challenge: Reuse and reprocessing of devices
As per the FDA and EU guidelines, ablation catheters are labeled as single-use devices (SUDs). However, high per-unit cost of these devices and limited reimbursement has led to their reprocessing and reuse, mainly in hospitals with budget constraints. The cost incurred by a hospital/surgical center for reprocessing and reuse is less than 10% of the cost of a new ablation device, reducing the overall procedural cost by around 50%.
Owing to this, many market leaders are now promoting refurbished devices through various programs. In May 2019, Stryker’s Sustainability Solutions segment, involved in reprocessing of electrophysiology (EP) catheters, EP cables, steerable introducer sheaths, and intracardiac echocardiography (ICE) catheters, sold its four-millionth reprocessed EP device. This equates to cost savings of more than USD 800 million for participating health systems.
The increasing demand for refurbished devices poses a major challenge for market players, especially for small manufacturers. To strengthen their position in the market and create a strong user base for their electrophysiology products, market players either have to position their products at lower prices or have to develop better or more advanced technologies that can address the unmet needs in the market.
“3D Mapping Systems: The largest segment of EP laboratory devices market”
Based on type of product, the EP laboratory devices market is segmented into 3D mapping systems, EP recording systems, RF ablation systems, intra-cardiac echocardiography (ICE) ultrasound imaging systems, EP X-ray systems, and other electrophysiology laboratory devices (MRI systems and EP remote magnetic and robotic navigation systems). 3D mapping systems accounted for the largest share of the global EP laboratory devices market in 2019. Driven by its high growth potential, markets players are increasingly focusing on the launch of new technologically advanced devices. For instance, in August 2018, BioSig Technologies received the US Food and Drug Administration (FDA) clearance for the PURE EP System.
“Cryoablation EP Catheters: The largest segment of EP ablation catheters market”
The EP ablation catheters market is further segmented into cryoablation EP catheters, radiofrequency ablation catheters, laser ablation systems, and microwave ablation systems. Cryoablation EP catheters accounted for the largest share of the global EP ablation catheters market in 2019. The therapeutic advantages of cryoablation over other ablation modalities such as radiofrequency ablation are driving the growth of this market. In addition, various market players are taking initiatives to increase their market presence and strengthen product portfolio; they are also engaging in clinical studies to evaluate the safety of their products. Such initiatives are further supporting market growth. In May 2019, Koninklijke Philips N.V. (Netherlands) entered into a partnership with Medtronic (Ireland). Philips’ KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software and services were expected to be leveraged to support cryoablation procedures performed using the Medtronic Arctic Front Advance cryoablation technology.
“Conventional EP Diagnostic Catheters: The largest segment of EP diagnostic catheters market”
On the basis of type, the EP diagnostic catheters market is segmented into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. The conventional EP diagnostic catheters segment accounted for the largest share of the global EP diagnostic catheters market in 2019. This can be attributed to the development of technologically advanced fixed and steerable diagnostic catheters, rising prevalence of cardiac arrhythmias across the globe, and increasing demand for these lower-priced devices in emerging markets.
Asia Pacific market to register highest growth for the electrophysiology market
The electrophysiology market in Asia Pacific, particularly in China, Japan, and India, is expected to witness high growth in the coming five years. China and India are expected to account for the highest growth; changing lifestyles and eating habits, increasing stress, and habitual smoking and drinking in these countries have resulted in growing health-related problems such as obesity, heart disease, and other chronic diseases. Factors such as the large population, increasing geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, increasing demand for advanced technologies, growing emphasis of prominent players on emerging markets, and less stringent regulations are also fueling the demand for electrophysiology devices in this region.
Key Market Players
Johnson & Johnson (US), Boston Scientific (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Royal Philips) (Netherlands), GE Healthcare (US), MicroPort Scientific Corporation (China), Stereotaxis (US), Imricor Medical Systems (US), EP Solutions (Switzerland), Epmap-System (Germany), OSYPKA AG (Germany), CardioFocus (US), CathVision (Denmark), Merit Medical Systems (US), BIOTRONIK (Germany), Siemens Healthineers (Germany), Lepu Medical (China), TZ Medical (US), Schwarzer Cardiotek GmbH (Germany), APN Health (US), Acutus Medical (US), Baylis Medical (Canada), Japan Lifeline (Japan), and CathRx (Australia).
In 2019, Johnson & Johnson dominated the electrophysiology. The company’s large share can be attributed to its strong suite of cardiac mapping systems, software, and electrophysiology catheters. Johnson & Johnson’s products are mainly targeted at the diagnosis and treatment of several cardiac arrhythmias, such as atrial fibrillation. The company has a strong geographic presence across the world. It focuses on product launches to establish a strong foothold in the market. In 2019, Biosense introduced CARTONET, a cloud-based networking and data analytics software solution.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
2018–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–205 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Product, Indication, End User, and Region |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (Japan, China, India, Australia, South Korea, and RoAPAC), Latin America (Brazil, Mexico, and, RoLA), and Middle East & Africa |
|
Companies Covered |
Johnson & Johnson (US), Boston Scientific (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Royal Philips) (Netherlands), GE Healthcare (US), MicroPort Scientific Corporation (China), Stereotaxis (US), Imricor Medical Systems (US), EP Solutions (Switzerland), Epmap-System (Germany), OSYPKA AG (Germany), CardioFocus (US), CathVision (Denmark), Merit Medical Systems (US), BIOTRONIK (Germany), Siemens Healthineers (Germany), Lepu Medical (China), TZ Medical (US), Schwarzer Cardiotek GmbH (Germany), APN Health (US), Acutus Medical (US), Baylis Medical (Canada), Japan Lifeline (Japan), and CathRx (Australia). Major 25 players covered. |
This research report categorizes the electrophysiology market based on product, indication, end user, and region.
Electrophysiology Market, by Product
- Electrophysiology Ablation Catheters
- Cryoablation Electrophysiology Catheters
- Radiofrequency Ablation Catheters
- Microwave Ablation (MWA) Systems
- Laser Ablation Systems
- Electrophysiology Laboratory Devices
- 3D Mapping Systems
- Electrophysiology Recording Systems
- Radiofrequency Ablation Systems
- Intracardiac Echocardiography (ICE) Ultrasound Imaging System
- Electrophysiology X-ray Systems
- Other Electrophysiology Laboratory Devices
- Electrophysiology Diagnostic Catheters
- Conventional Electrophysiology Diagnostic Catheters
- Advanced Electrophysiology Diagnostic Catheters
- Ultrasound Electrophysiology Diagnostic Catheters
- Access Devices
- Other Products
- Electrophysiology Diagnostic Catheters
Electrophysiology Market, by Indication
- Atrial Fibrillation
- Atrial Flutter
- Atrioventricular Nodal Reentry Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WPW)
- Other Indications
Electrophysiology Market, by End User
- Hospitals & Cardiac Centers
- Ambulatory Surgery Centers
Electrophysiology Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Middle East & Africa
Recent Developments
- In March 2020, Stereotaxis (US) announced FDA clearance and US launch of the Genesis RMN System.
- In June 2019, Abbott entered into a partnership with CARE (Switzerland). Under this partnership, Abbott announced a three-year program to screen, diagnose, prevent, and manage noncommunicable diseases (NCDs), such as diabetes, cardiovascular diseases, and other chronic diseases, for people who were displaced after the armed conflict in Marawi, Philippines.
- In January 2019, Medtronic entered into an agreement with EPIX Therapeutics (US) to expand Medtronic’s cardiac ablation portfolio with the addition of EPIX’s proprietary catheter-based, temperature-controlled cardiac ablation system for treating patients with cardiac arrhythmias.
- In June 2018, Koninklijke Philips N.V. acquired EPD Solutions (Israel), an innovator in image-guided procedures for cardiac arrhythmias, in order to strengthen Philips’ portfolio of interventional imaging systems.
- In April 2018, Boston Scientific Corporation acquired Securus Medical Group, Inc. (US) to enhance Boston Scientific’s electrophysiology cardiac ablation portfolio.
Frequently Asked Questions (FAQ):
What is the expected addressable market value of major electrophysiology products over a 5-year period?
The global electrophysiology market is estimated to reach USD 10,611 million in 2025 from USD 6,866 million in 2020, at a CAGR of 9.1% during the forecast period.
Which product segment is expected to garner highest traction within the electrophysiology market?
Based on product, the electrophysiology market is segmented into EP laboratory devices, EP ablation catheters, EP diagnostic catheters, access devices, and other products. The EP laboratory devices segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the growing focus of market players on the launch of technologically advanced 3D mapping systems, increasing public private funding for the development of novel electrophysiology recording systems, rising number of RF ablation procedures, cost effectiveness of RF ablation procedures as compared to other ablation techniques, and increasing availability of these products in major markets.
What are the major factors expected to limit the growth of the electrophysiology market?
The reuse and reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market.
What are the major revenue pockets in the electrophysiology market currently?
The Asia Pacific (APAC) market is expected to record the highest CAGR during the forecast period. Growth in this region can be attributed to the favorable reimbursement scenario in Japan, the growing geriatric population in China, increasing government initiatives towards healthcare in India and South Korea, and the rising incidence of target diseases.
Who all are the key players operating in the electrophysiology market and what are the key growth strategies applied?
The electrophysiology market is diversified and competitive, with a large number of players dominating different product segments, depending on their core competencies. As of 2019, the electrophysiology market was dominated by Johnson & Johnson (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Royal Philips) (Netherlands), GE Healthcare (US), and Boston Scientific (US). The players adopted key strategies, such as, new product launches, partnerships, acquisitions, agreements, and alliances to increase their market penetration. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 43)
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020-2025)
4 PREMIUM INSIGHTS (Page No. - 47)
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS – KEY FACTORS DRIVING GROWTH OF GLOBAL ELECTROPHYSIOLOGY MARKET
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED THE ASIA PACIFIC ELECTROPHYSIOLOGY MARKET IN 2019
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND REGION
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2019
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
4.5 GEOGRAPHICAL SNAPSHOT OF THE ELECTROPHYSIOLOGY MARKET
FIGURE 15 CHINA MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2020-2025)
5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
FIGURE 16 EVOLUTION OF ELECTROPHYSIOLOGY
5.2 MARKET DYNAMICS
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Technological advancements
5.2.1.1.1 Non-invasive cardiac mapping
5.2.1.1.2 Improved ablation
5.2.1.1.3 MRI guided ablation procedures
5.2.1.1.4 Ultrasound guidance in the EP Lab
5.2.1.2 New entrants in the market
TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
5.2.1.3 Growing investments, funds, and grants
5.2.1.4 Increasing incidence of target diseases and procedures
5.2.2 RESTRAINTS
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement
5.2.2.2 Unfavorable healthcare reforms in the US
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Reuse and reprocessing of devices
5.2.4.2 Lack of skilled and experienced electrophysiologists
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 REGULATORY ANALYSIS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 COVID-19 IMPACT ON THE ELECTROPHYSIOLOGY MARKET
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT (Page No. - 71)
6.1 INTRODUCTION
TABLE 8 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES
TABLE 9 EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 EP LABORATORY DEVICES MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 11 EP LABORATORY DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 12 EP LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.1 3D MAPPING SYSTEMS
6.2.1.1 Alternative technologies likely to hinder market growth
TABLE 13 3D MAPPING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS
6.2.2.1 Increasing public-private funding to support market growth
TABLE 14 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS
6.2.3.1 Increased demand due to rising number of RF ablation procedures
TABLE 15 RF ABLATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUNG IMAGING SYSTEMS
6.2.4.1 Advantages of ICE ultrasound imaging systems to support market growth
TABLE 16 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS
6.2.5.1 Magnetic navigation systems to hamper market growth
TABLE 17 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.6 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES
6.2.6.1 Favorable reimbursement likely to bolster growth of market
TABLE 18 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS
TABLE 19 EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 20 EP ABLATION CATHETERS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 21 EP ABLATION CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 22 EP ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
6.3.1.1 Significant therapeutic advantages to contribute to market growth
TABLE 23 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS
6.3.2.1 Technological advancements to drive the market
TABLE 24 RF ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS
6.3.3.1 Advantages over RF ablation catheters to support market growth
TABLE 25 MWA SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.4 LASER ABLATION SYSTEMS
6.3.4.1 Technologically advanced products to boost market growth
TABLE 26 LASER ABLATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
TABLE 27 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 28 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 29 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 30 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1.1 Increasing demand in emerging markets to support market growth
TABLE 31 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.2.1 Advantages over conventional EP diagnostic catheters likely to drive market growth
TABLE 32 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems
TABLE 33 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 ACCESS DEVICES
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS LIKELY TO SUPPORT MARKET GROWTH
TABLE 34 ACCESS DEVICES MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 35 ACCESS DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 36 ACCESS DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.6 OTHER PRODUCTS
TABLE 37 OTHER PRODUCTS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 38 OTHER PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION (Page No. - 94)
7.1 INTRODUCTION
TABLE 40 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH
TABLE 41 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2018–2025 (USD MILLION)
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER CONTRIBUTING TO MARKET GROWTH
TABLE 42 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2018–2025 (USD MILLION)
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT SUPPORTING SEGMENT GROWTH
TABLE 43 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2018–2025 (USD MILLION)
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WPW LIKELY TO SUPPORT MARKET GROWTH
TABLE 44 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2018–2025 (USD MILLION)
7.6 OTHER INDICATIONS
TABLE 45 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD MILLION)
8 ELECTROPHYSIOLOGY MARKET, BY END USER (Page No. - 101)
8.1 INTRODUCTION
TABLE 46 ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 HOSPITALS & CARDIAC CENTERS
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET
TABLE 47 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2018–2025 (USD MILLION)
8.3 AMBULATORY SURGERY CENTERS
8.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
TABLE 48 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2018–2025 (USD MILLION)
9 ELECTROPHYSIOLOGY MARKET, BY REGION (Page No. - 105)
9.1 INTRODUCTION
TABLE 49 ELECTROPHYSIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 56 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Technological advancements driving market growth
TABLE 57 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES
TABLE 58 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 59 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing government funding for research to support market growth
TABLE 62 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 63 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 64 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 67 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 69 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 73 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth
TABLE 74 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 75 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Growing geriatric population to support market growth
TABLE 78 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing incidence of heart failure to support market growth
TABLE 82 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising incidence of CVDs to drive the adoption of electrophysiology devices
TABLE 86 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing number of cardiac ablation procedures to drive market
TABLE 90 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 94 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 95 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 96 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
TABLE 99 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 101 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Favorable reimbursement scenario to support market growth
TABLE 106 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 107 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing geriatric population to drive the market
TABLE 110 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing healthcare initiatives by government supporting growth of market
TABLE 114 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 115 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increasing target disease burden to support market growth
TABLE 118 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 119 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives expected to positively impact market growth
TABLE 122 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 123 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 126 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 127 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 130 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 132 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 136 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Key market owing to modernization of healthcare facilities
TABLE 137 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 138 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 141 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 142 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 145 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 146 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 149 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 150 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 154 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 159)
10.1 INTRODUCTION
FIGURE 23 KEY DEVELOPMENTS IN THE ELECTROPHYSIOLOGY MARKET, 2017–2019
10.2 MARKET SHARE ANALYSIS
FIGURE 24 ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNCHES & APPROVALS
TABLE 155 PRODUCT LAUNCHES & APPROVALS (2017–2019)
10.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 156 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
10.3.3 ACQUISITIONS
TABLE 157 ACQUISITIONS (2017–2019)
11 COMPANY EVOLUTION MATRIX & COMPANY PROFILES (Page No. - 163)
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY
11.1.1 COMPETITVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS
11.1.2 VISIONARY LEADERS
11.1.3 INNOVATORS
11.1.4 EMERGING COMPANIES
11.1.5 DYNAMIC DIFFERENTIATORS
FIGURE 25 ELECTROPHYSIOLOGY MARKET COMPETITIVE LEADERSHIP MAPPING, 2019
11.2 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, Competitive analysis)*
11.2.1 JOHNSON & JOHNSON
FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
11.2.2 ABBOTT LABORATORIES
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.2.3 MEDTRONIC PLC
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
11.2.4 KONINKLIJKE PHILIPS N.V.
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
11.2.5 GE HEALTHCARE
FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
11.2.6 BOSTON SCIENTIFIC CORPORATION
FIGURE 31 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.2.7 JAPAN LIFELINE
FIGURE 32 JAPAN LIFELINE: COMPANY SNAPSHOT (2019)
11.2.8 STEREOTAXIS
FIGURE 33 STEREOTAXIS: COMPANY SNAPSHOT (2019)
11.2.9 MICROPORT SCIENTIFIC CORPORATION
FIGURE 34 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.2.10 BIOTRONIK
11.2.11 ACUTUS MEDICAL
11.2.12 BAYLIS MEDICAL
11.2.13 EP SOLUTIONS SA
11.2.14 APN HEALTH, LLC
11.2.15 OSYPKA
11.2.16 EPMAP-SYSTEM
11.2.17 OTHER COMPANIES
11.2.17.1 CathRx Ltd
11.2.17.2 Merit Medical Systems
11.2.17.3 Cook Medical
11.2.17.4 CathVision
11.2.17.5 TZ Medical
11.2.17.6 Teleflex
11.2.17.7 Lepu Medical
11.2.17.8 Cardiofocus
11.2.17.9 Schwarzer Cardiotek
11.2.17.10 Imricor Medical Systems
*Business Overview, Products Offered, Recent Developments, Competitive analysis View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 203)
12.1 DISCUSSION GUIDE: ELECTROPHYSIOLOGY MARKET
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the electrophysiology market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the breast biopsy market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, ambulatory surgery centers, outpatient facilities, clinics, research universities, academic institutions, and government institutions, among others) and supply-side (such as OEMs, third party suppliers, and distributors). Approximately 30% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
Market Size Estimation
All major product manufacturers offering various electrophysiology products were identified at the global/regional level. Revenue mapping was done for the major players (who contribute at least 90-95% of the overall market share at the global level) and was extrapolated to arrive at the global market value of each product segment. The market value of electrophysiology products was also split into various segments and subsegments at the region and country-level based on:
- Product mapping of various manufacturers for each type of electrophysiology product at the regional and country-level
- Relative adoption pattern of each electrophysiology product among key end users at the regional and/or country-level
- Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level
- Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the breast biopsy industry.
Report Objectives
- To define, describe, and forecast the breast biopsy market by product, indication, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micro markets with respect to their growth trends, prospects, and contributions to the total market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the revenue of market segments with respect to five regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and RoLA), and the Middle East & Africa
- To strategically profile the key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as alliances, agreements, collaborations, partnerships, market developments, acquisitions, expansions, and product launches & approvals in the electrophysiology market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global electrophysiology market report:
Company Information
- Detailed analysis and profiling of additional market players (up to 3)
Get in-depth analysis of the COVID-19 impact on the Electrophysiology Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Electrophysiology Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Electrophysiology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Electrophysiology Market